Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy

Abstract Background Accumulating evidence indicate that circulating microRNAs (miRNAs) are useful independent non-invasive biomarkers, with unique miRNA signatures defined for various pathophysiological conditions. However, there are no established universal housekeeping miRNAs for the normalisation...

Full description

Bibliographic Details
Main Authors: J. W. Tay, I. James, Q. W. Hughes, J. Y. Tiao, R. I. Baker
Format: Article
Language:English
Published: BMC 2017-07-01
Series:BMC Research Notes
Online Access:http://link.springer.com/article/10.1186/s13104-017-2636-3
_version_ 1819080796576677888
author J. W. Tay
I. James
Q. W. Hughes
J. Y. Tiao
R. I. Baker
author_facet J. W. Tay
I. James
Q. W. Hughes
J. Y. Tiao
R. I. Baker
author_sort J. W. Tay
collection DOAJ
description Abstract Background Accumulating evidence indicate that circulating microRNAs (miRNAs) are useful independent non-invasive biomarkers, with unique miRNA signatures defined for various pathophysiological conditions. However, there are no established universal housekeeping miRNAs for the normalisation of miRNAs in body fluids. We have previously identified an oestrogen-responsive miRNA, miR-494, in regulating the anticoagulant, Protein S, in HuH-7 liver cells. Moreover, increased thrombotic risk associated with elevated circulating oestrogen levels is frequently observed in pregnant women and oral contraceptive users. In order to identify other oestrogen-responsive miRNAs, including miR-494, that may be indicative of increased thrombotic risk in plasma, we used nanoString analysis to identify robust and stable endogenous reference miRNAs for the study of oestrogen-responsive miRNAs in plasma. Results We compared the plasma miRNA expression profile of individuals with: (1) Low circulating oestrogens (healthy men and non-pregnant women not taking oral contraceptives), (2) High circulating synthetic oestrogens, (women taking oral contraceptives) and (3) High circulating natural oestrogens (pregnant females >14 weeks gestation). From the nanoString analyses, 11 candidate reference miRNAs which exhibited high counts and not significantly differentially expressed between groups were selected for validation using realtime quantitative polymerase chain reaction (RT-qPCR) and digital droplet PCR (DDPCR) in pooled plasma samples, and the stability of their expression evaluated using NormFinder and BestKeeper algorithms. Four miRNAs (miR-25-5p, miR-188-5p, miR-222-3p and miR-520f) demonstrated detectable stable expression between groups and were further analysed by RT-qPCR in individual plasma samples, where miR-188-5p and miR-222-3p expression were identified as a stable pair of reference genes. The miRNA reference panel consisting of synthetic spike-ins cel-miR-39 and ath-miR159a, and reference miRNAs, miR-188-5p and miR-222-3p was useful in evaluating fold-change of the pregnancy-associated miRNA, miR-141-3p, between groups. Conclusion The miRNA reference panel will be useful for normalising qPCR data comparing miRNA expression between men and women, non-pregnant and pregnant females, and the potential effects of endogenous and synthetic oestrogens on plasma miRNA expression.
first_indexed 2024-12-21T19:50:35Z
format Article
id doaj.art-4dea9522c2dd48b183ff7eabe2134749
institution Directory Open Access Journal
issn 1756-0500
language English
last_indexed 2024-12-21T19:50:35Z
publishDate 2017-07-01
publisher BMC
record_format Article
series BMC Research Notes
spelling doaj.art-4dea9522c2dd48b183ff7eabe21347492022-12-21T18:52:14ZengBMCBMC Research Notes1756-05002017-07-0110111210.1186/s13104-017-2636-3Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancyJ. W. Tay0I. James1Q. W. Hughes2J. Y. Tiao3R. I. Baker4Western Australian Centre for Thrombosis and Haemostasis, Murdoch UniversityInstitute for Immunology and Infectious Diseases, Murdoch UniversityWestern Australian Centre for Thrombosis and Haemostasis, Murdoch UniversityWestern Australian Centre for Thrombosis and Haemostasis, Murdoch UniversityWestern Australian Centre for Thrombosis and Haemostasis, Murdoch UniversityAbstract Background Accumulating evidence indicate that circulating microRNAs (miRNAs) are useful independent non-invasive biomarkers, with unique miRNA signatures defined for various pathophysiological conditions. However, there are no established universal housekeeping miRNAs for the normalisation of miRNAs in body fluids. We have previously identified an oestrogen-responsive miRNA, miR-494, in regulating the anticoagulant, Protein S, in HuH-7 liver cells. Moreover, increased thrombotic risk associated with elevated circulating oestrogen levels is frequently observed in pregnant women and oral contraceptive users. In order to identify other oestrogen-responsive miRNAs, including miR-494, that may be indicative of increased thrombotic risk in plasma, we used nanoString analysis to identify robust and stable endogenous reference miRNAs for the study of oestrogen-responsive miRNAs in plasma. Results We compared the plasma miRNA expression profile of individuals with: (1) Low circulating oestrogens (healthy men and non-pregnant women not taking oral contraceptives), (2) High circulating synthetic oestrogens, (women taking oral contraceptives) and (3) High circulating natural oestrogens (pregnant females >14 weeks gestation). From the nanoString analyses, 11 candidate reference miRNAs which exhibited high counts and not significantly differentially expressed between groups were selected for validation using realtime quantitative polymerase chain reaction (RT-qPCR) and digital droplet PCR (DDPCR) in pooled plasma samples, and the stability of their expression evaluated using NormFinder and BestKeeper algorithms. Four miRNAs (miR-25-5p, miR-188-5p, miR-222-3p and miR-520f) demonstrated detectable stable expression between groups and were further analysed by RT-qPCR in individual plasma samples, where miR-188-5p and miR-222-3p expression were identified as a stable pair of reference genes. The miRNA reference panel consisting of synthetic spike-ins cel-miR-39 and ath-miR159a, and reference miRNAs, miR-188-5p and miR-222-3p was useful in evaluating fold-change of the pregnancy-associated miRNA, miR-141-3p, between groups. Conclusion The miRNA reference panel will be useful for normalising qPCR data comparing miRNA expression between men and women, non-pregnant and pregnant females, and the potential effects of endogenous and synthetic oestrogens on plasma miRNA expression.http://link.springer.com/article/10.1186/s13104-017-2636-3
spellingShingle J. W. Tay
I. James
Q. W. Hughes
J. Y. Tiao
R. I. Baker
Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy
BMC Research Notes
title Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy
title_full Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy
title_fullStr Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy
title_full_unstemmed Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy
title_short Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy
title_sort identification of reference mirnas in plasma useful for the study of oestrogen responsive mirnas associated with acquired protein s deficiency in pregnancy
url http://link.springer.com/article/10.1186/s13104-017-2636-3
work_keys_str_mv AT jwtay identificationofreferencemirnasinplasmausefulforthestudyofoestrogenresponsivemirnasassociatedwithacquiredproteinsdeficiencyinpregnancy
AT ijames identificationofreferencemirnasinplasmausefulforthestudyofoestrogenresponsivemirnasassociatedwithacquiredproteinsdeficiencyinpregnancy
AT qwhughes identificationofreferencemirnasinplasmausefulforthestudyofoestrogenresponsivemirnasassociatedwithacquiredproteinsdeficiencyinpregnancy
AT jytiao identificationofreferencemirnasinplasmausefulforthestudyofoestrogenresponsivemirnasassociatedwithacquiredproteinsdeficiencyinpregnancy
AT ribaker identificationofreferencemirnasinplasmausefulforthestudyofoestrogenresponsivemirnasassociatedwithacquiredproteinsdeficiencyinpregnancy